Emergent BioSolutions (EBS) Reports Q1 Loss of $3.17
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.76 +3.21%
Revenue Growth %: -45.6%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -45.6%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
(Updated - May 9, 2023 5:00 PM EDT)
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of ($3.17), versus $0.00 reported last year. Revenue for the quarter came in at $165.1 million versus the consensus estimate of $175.12 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Talos Energy closes $420M Gulf of America deepwater asset deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
